Skip to content

NEURO

Active Private limited companyfounded 1988active for 38 yearsWinston Churchilllaan 192, 1180 UccleKBO/BCE: BE 0434.564.750

Lifetime

20 annual accounts with figures on one time axis, 36 filings since 1990
peak of €609,728 in 2009
-€28,023▼ €184,078
lowest -€95,605 in 2025
-€95,605▼ €206,024
peak of €916,315 in 2009
€634,137▼ 2.5%
€117,292▲ 38.4%
Board1 name since 2021
1 director
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Gross margin from €156,055 to -€28,023Loss of €95,605Debts from €84,733 to €117,292Investments €60,730

Key points

from the 2025 annual accounts

Result

-€95,605 -€95,605
€110,0002024-€95,6002025

From profit to loss in 2025, after a profit of €110,419 in 2024.

Investments

€60,730 2.2 times depreciation
2022202320242025

Green is investment, beige is depreciation.

Position in the sector

-€95,605

Lower net result than 92% of companies in research and development. Sector median €23,659 · 669 companies.

Turnover not published in the micro format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 926 companies had the same profile as NEURO has now. Each dot stands for 3 companies, two years later.

90.0%
were still trading
9.0%
stopped another way
1.1%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 926 companies, not a prediction for NEURO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • associé uniquedeed of 30-07-2013
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0434564750
Amendment of the articles · Legal-form change · Resignations & appointments appointed as statutory director · General meeting of 07-11-2023 · Gazette deed
Amendment of the articles “L'exercice de la Médecine et de la totalité d'une activité médicale et ce, par l'intermédiaire de ses organes…” (deed in French) · Partner: (associé unique) · General meeting of 03-07-2013 · Gazette deed
Purpose change · Amendment of the articles “Activités en neurosciences et neuromanagement par production, publications et éditions d'enseignements, de…” (deed in French) · General meeting of 29-03-2012 · Gazette deed
All 50 events

Comparable companies

same main activity, similar in size and age
Company
NEURO Uccle €0.8m -€28,023 84.4% -
LBG Grimbergen €0.3m -€1,696 85.8% -
BREACH Brussels €0.9m -€286,586 83.3% -
CARDIO OV Brakel €0.3m -€15,007 60.2% -
Centre for European Policy Studies Brussels €5.4m - 11.1% 55.4
GROUPE DE RECHERCHE ET D'INTERVENTION EN RESSOURCES HUMAINES Soumagne €0.7m €24,131 96.5% -
BIAS, BEGELEIDING IN ARBEIDSGEBONDEN STRESS As €0.5m €24,208 99.3% -

These companies have the same main activity as NEURO: scientific research and development (NACE 72200). They are comparable in size and age: total assets between €274,000 and €5.4m, founded between 1983 and 2014.

Official details

Source: KBO
Status
Active since 15-06-1988Normal situation
Activity
Scientific research and developmentNACE 72200
Establishment unit
2.047.331.1911050 Brussels, since 06-03-1990
Financial year end
31 December
Peppol
Reachable since 17-09-2025
Company details

Annual accounts 2025

€751,429▼ 7.7%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on NEURO

NEURO files the micro format. That format states no turnover. The gross margin fell from €102,506 in 2006 to -€28,023 in 2025.

The balance sheet grew most from 2008 to 2009 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NEURO

What is the company number of NEURO?
The company number of NEURO is 0434.564.750. The VAT number is the same number with BE in front: BE 0434.564.750.
Where is NEURO based?
The registered office is at Winston Churchilllaan 192, 1180 Uccle.Company details
What does NEURO do?
According to the KBO register, the main activity is scientific research and development (NACE 72200).
What is the legal form of NEURO?
NEURO is a private limited company (BV).
When was NEURO founded?
NEURO was founded on 15-06-1988.
Is NEURO still active?
Yes, NEURO is an active enterprise in the KBO register.
What is the turnover of NEURO?
The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
Is NEURO profitable?
In financial year 2025, NEURO made a loss of €95,605.
Where can I find the annual accounts of NEURO?
NEURO filed 36 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of NEURO due?
NEURO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.